David Goodman-Meza

InstitutionDivision of Infectious Diseases
AddressLos Angeles
California
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 11 Covid-19 publications, with a maximum of 2 publications in July 2020 and December 2020 and June 2021
    All Publications
    Bar chart showing 28 publications over 8 distinct years, with a maximum of 6 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Yang B, Fulcher JA, Ahn J, Berro M, Goodman-Meza D, Dhody K, Sacha JB, Naeim A, Yang OO. Clinical Characteristics and Outcomes of Coronavirus Disease 2019 Patients Who Received Compassionate-Use Leronlimab. Clin Infect Dis. 2021 12 06; 73(11):e4082-e4089. PMID: 33079180.
      Citations: 8     Fields:    Translation:Humans
    2. Vijayan T, Shin M, Adamson PC, Harris C, Seeman T, Norris KC, Goodman-Meza D. Beyond the 405 and the 5: Geographic Variations and Factors Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity Rates in Los Angeles County. Clin Infect Dis. 2021 11 02; 73(9):e2970-e2975. PMID: 33141164.
      Citations: 2     Fields:    Translation:Humans
    3. Esquer Garrigos Z, Wingler MJB, Svoronos PA, Vijayvargiya P, Goodman-Meza D, O'Horo JC, Navalkele BD, Cretella D, Frame IJ, Parham J, Lucar J. Increased rates of blood culture contamination during the coronavirus disease 2019 pandemic. Infect Control Hosp Epidemiol. 2021 Jun 24; 1-3. PMID: 34247662.
      Citations: 1     Fields:    
    4. Ibarrondo FJ, Hofmann C, Fulcher JA, Goodman-Meza D, Mu W, Hausner MA, Ali A, Balamurugan A, Taus E, Elliott J, Krogstad P, Tobin NH, Ferbas KG, Kitchen SG, Aldrovandi GM, Rimoin AW, Yang OO. Primary, Recall, and Decay Kinetics of SARS-CoV-2 Vaccine Antibody Responses. ACS Nano. 2021 Jun 23. PMID: 34159781.
      Citations: 3     Fields:    
    5. Saab FG, Chiang JN, Brook R, Adamson PC, Fulcher JA, Halperin E, Manuel V, Goodman-Meza D. Discharge Clinical Characteristics and Post-Discharge Events in Patients with Severe COVID-19: A Descriptive Case Series. J Gen Intern Med. 2021 Apr; 36(4):1017-1022. PMID: 33532963.
      Citations: 2     Fields:    Translation:Humans
    6. Herring AA, Kalmin M, Speener M, Goodman-Meza D, Snyder H, Campbell A, Moulin A, Shoptaw S. Sharp decline in hospital and emergency department initiated buprenorphine for opioid use disorder during COVID-19 state of emergency in California. J Subst Abuse Treat. 2021 Apr; 123:108260. PMID: 33612194.
      Citations: 2     Fields:    Translation:Humans
    7. Monteiro AC, Suri R, Emeruwa IO, Stretch RJ, Cortes-Lopez RY, Sherman A, Lindsay CC, Fulcher JA, Goodman-Meza D, Sapru A, Buhr RG, Chang SY, Wang T, Qadir N. Obesity and smoking as risk factors for invasive mechanical ventilation in COVID-19: A retrospective, observational cohort study. PLoS One. 2020; 15(12):e0238552. PMID: 33351817.
      Citations: 13     Fields:    Translation:Humans
    8. Goodman-Meza D, Rudas A, Chiang JN, Adamson PC, Ebinger J, Sun N, Botting P, Fulcher JA, Saab FG, Brook R, Eskin E, An U, Kordi M, Jew B, Balliu B, Chen Z, Hill BL, Rahmani E, Halperin E, Manuel V. A machine learning algorithm to increase COVID-19 inpatient diagnostic capacity. PLoS One. 2020; 15(9):e0239474. PMID: 32960917.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    9. Adamson PC, Goodman-Meza D, Vijayan T, Yang S, Garner OB. Diagnostic yield of repeat testing for SARS-CoV-2: Experience from a large health system in Los Angeles. Int J Infect Dis. 2020 Nov; 100:298-301. PMID: 32835787.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    10. Ibarrondo FJ, Fulcher JA, Goodman-Meza D, Elliott J, Hofmann C, Hausner MA, Ferbas KG, Tobin NH, Aldrovandi GM, Yang OO. Rapid Decay of Anti-SARS-CoV-2 Antibodies in Persons with Mild Covid-19. N Engl J Med. 2020 09 10; 383(11):1085-1087. PMID: 32706954.
      Citations: 352     Fields:    Translation:HumansCellsPHPublic Health
    11. Shoptaw S, Goodman-Meza D, Landovitz RJ. Collective Call to Action for HIV/AIDS Community-Based Collaborative Science in the Era of COVID-19. AIDS Behav. 2020 07; 24(7):2013-2016. PMID: 32300993.
      Citations: 10     Fields:    
    Goodman-Meza's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (85)
    Explore
    _
    Co-Authors (80)
    Explore
    _
    Similar People (60)
    Explore
    _